GIA Clinical Trials, LLC

Knoxville, Tennessee 37909

1 studies enrolling now · 5 studies all time

What they study most

Cancer, Crohn's Disease, Primary Biliary Cholangitis, Ulcerative Colitis

Studies at this site

• Prospective Study to Assess a Diagnostic Aid for Cancer — Recruiting now
• Development and Validation of Harbinger Health Test for Early Cancer Detection — Completed
• A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Completed
• Study of the Efficacy and Safety of AMT-101 in Subjects With Ulcerative Colitis (LOMBARD) — Status unconfirmed
• ENHANCE: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA) — Completed